scholarly journals Evaluation of white blood cell and neutrophil/lymphocyte ratio in acute coronary syndrome patients admitted to emergency department

2018 ◽  
Vol 29 (10) ◽  
Author(s):  
Mustafa Ugur Goktas ◽  
Pinar Yesim Akyol ◽  
Zeynep Karakaya ◽  
Umut Payza ◽  
Fatih Esad Topal
QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Sarah Mohamed Mahmoud ◽  
Bassam Sobhy ◽  
Ramy Raymond

Abstract Background The neutrophil–lymphocyte ratio (NLR) is considered an independent predictor of mortality and myocardial infarction (MI) in stable coronary artery disease (SCAD). Also NLR have prognostic value in patients with acute coronary syndromes (ACSs). However the diagnostic power of NLR in patients suspected of ACS is still under study Objective is to determine the ability of neutrophil-lymphocyte ratio to predict troponin elevation in patients presenting to emergency department with acute coronary syndrome Material and Methods From June 2018 to March 2019, 100 patients were enrolled who presented to the ER with NST-ACS. Patients were divided into 2 groups based upon the troponin positivity in the 12- to 24-hour follow-up. Baseline Complete blood count with calculation of NLR is done Results The study population was divided into 2 groups: troponin- negative group (n = 50) and troponin-positive group (n = 50). Mean age was 55.8 ± 11.3. 77% of the patients were male. No significance difference in the level of hemoglobin, WBCs and platelets between the 2 groups. The neutrophil count was significantly higher in the troponin-positive group (p < 0.001). The median admission. NLR was significantly higher in the troponin-positive group (2 vs. 3.9, P < 0.001). A cutoff point of 3.4 for NLR measured on admission had 84% sensitivity and 84% specificity in predicting follow-up troponin positivity. A highly significant correlation was found between NLR and level of troponin change (p value <0.01) Conclusion NLR can be used as a diagnostic tool in the differentiation of patients with acute coronary syndrome. NLR is a non-expensive, simple and available parameter that can be used in diagnosis of NSTEMI.


2018 ◽  
Vol 39 (suppl_1) ◽  
Author(s):  
L Graca Santos ◽  
C Ruivo ◽  
F Montenegro Sa ◽  
R Ribeiro Carvalho ◽  
F Saraiva ◽  
...  

2018 ◽  
pp. 103-106
Author(s):  
Tugba Atmaca Temrel ◽  
◽  
Gul Pamukcu Gunaydin ◽  
Servan Gokhan ◽  
Ayhan Ozhasenekler ◽  
...  

2007 ◽  
Vol 22 (Suppl) ◽  
pp. S104 ◽  
Author(s):  
Mi Sook Gwak ◽  
Soo Joo Choi ◽  
Jie Ae Kim ◽  
Justin Sang Ko ◽  
Tae Hyeong Kim ◽  
...  

Angiology ◽  
2011 ◽  
Vol 63 (1) ◽  
pp. 24-29 ◽  
Author(s):  
Kadhim Sulaiman ◽  
Ibrahim Al-Zakwani ◽  
Prashanth Panduranga ◽  
Jassim Al-Suwaidi ◽  
Alawi A. Alsheikh-Ali ◽  
...  

We evaluated the relationship between admission white blood cell (WBC) count and in-hospital outcomes in acute coronary syndrome (ACS) patients from the Middle East. Data were analyzed from 7806 consecutive patients with ACS who were divided into 4 groups (G) according to their WBC count (×109/L; G1: <6.00; G2: 6.00-9.99; G3: 10.00-11.99; G4: ≥12.00). After significant covariate adjustment, those in G4 were 68% more likely to have cardiogenic shock than those in G1 (95% confidence interval [CI]: 1.05-2.68; P = .030) and G2 (odds ratio [OR], 2.02; 95% CI: 1.51-2.71; P < .001). Those in G4 were 2.02 times (95% CI: 1.11-3.67; P = .021) and 65% (95% CI: 1.17-2.32; P = .004) more likely to die in hospital than those in G1 and G2, respectively. Admission WBC count is an independent risk factor for in-hospital cardiogenic shock and mortality, in Middle Eastern patients with ACS. Novel therapeutic agents targeting WBCs in patients with ACS may improve outcomes.


Sign in / Sign up

Export Citation Format

Share Document